O
Ocimum Biosolutions
Genomics company providing glp-compliant microarray services, reference databases and other life science solutions
About Ocimum Biosolutions
Ocimum Biosolutions provides a range of solutions for efficient laboratory data and sample management, catering primarily to the biopharmaceutical industry. The company offers a suite of products including Sciantis, an intuitive tool for biologics process tracking and data management, and a comprehensive data analysis suite featuring gene expression reference databases and predictive toxicogenomics models. Ocimum's business model revolves around offering GLP-compliant lab services such as gene and microRNA expression profiling, SNP genotyping, and biomarker discovery, supporting clinical trials and research. The company generates revenue through its software solutions and lab services, serving clients in the biopharma sector.
Source: Dealroom company dataAt a glance
- Founded
- 2000
- Headquarters
- Gaithersburg, United States
- Sector
- Biotechnology
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- KFKubera Cross-Border Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ocimum Biosolutions on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ocimum Biosolutions on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.